Cargando...
Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy
Neoadjuvant chemotherapy is the current standard of care for large, advanced, and/or inoperable tumors, including triple‐negative breast cancer. Although the clinical benefits of neoadjuvant chemotherapy have been illustrated through numerous clinical trials, more than half of the patients do not ex...
Gardado en:
| Publicado en: | Cancer Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7476842/ https://ncbi.nlm.nih.gov/pubmed/32692484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3284 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|